Cargando…
CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis
INTRODUCTION: Enhanced B cell activity, particularly memory B cells have gained interest in evaluating response during therapies with biologics. CD27-IgD- double-negative (DN) B cells lacking the conventional memory marker CD27 are reported to be part of the memory compartment, however, only scarce...
Autores principales: | Mahmood, Zafar, Muhammad, Khalid, Schmalzing, Marc, Roll, Petra, Dörner, Thomas, Tony, Hans-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415279/ https://www.ncbi.nlm.nih.gov/pubmed/25888920 http://dx.doi.org/10.1186/s13075-015-0580-y |
Ejemplares similares
-
Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients
por: Mahmood, Zafar, et al.
Publicado: (2020) -
Impaired CD27(+)IgD(+) B Cells With Altered Gene Signature in Rheumatoid Arthritis
por: Hu, Fanlei, et al.
Publicado: (2018) -
Interleukin 1 blockade withcanakinumab for Hyper IGD syndrome (HIDS)
por: Brunnner, J, et al.
Publicado: (2015) -
Interleukin-6 Receptor Blockade Selectively Reduces IL-21 Production by CD4 T Cells and IgG4 Autoantibodies in Rheumatoid Arthritis
por: Carbone, Gustavo, et al.
Publicado: (2013) -
Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig
por: Zhang, Jing, et al.
Publicado: (2020)